Note 6 - Stockholders' Equity

3 Months Ended

Mar. 31, 2025

Notes to Financial Statements

Equity [Text Block]

NOTE 6— STOCKHOLDERS’ EQUITY

PUBLIC OFFERING 

On  January 12, 2024 the underwriter exercised its over-allotment option as to 372,110 shares of common stock for net proceeds after discounts and commission of $192,156.

WARRANTS

As of  March 31, 2025, the Company had no outstanding warrants.

SHARES TO BE ISSUED

As of March 31, 2025 and 2024, there were 3,076,871 and 2,979,994, respectively, shares to be issued whose issuance has been deferred under the terms of employment and consulting agreements with officers and directors and other employees of Milestone Scientific. Such shares will be issued to each party upon termination of their employment or other relationship with the Company. 

As of March 31, 2025 and 2024, there were 631,792 and 527,624, respectively, shares to be issued to non-employees, that will be issued to non-employees for services rendered. The number of shares was fixed by contract prior to the date of grant, subject to performance, and were fully earned upon the grant date.

The following table summarizes information about shares to be issued for the three month periods ending March 31, 2025 and 2024.

	March 31, 2025		March 31, 2024
Shares-to-be-issued, outstanding January 1, 2025 and 2024, respectively		3,393,017		3,098,917
Granted in current period		315,646		438,868
Issued in current period		-		(30,167	)
Shares-to be issued outstanding March 31, 2025 and 2024, respectively		3,708,663		3,507,618